190 related articles for article (PubMed ID: 35280824)
1. All-
Benjamin DN; O'Donovan TR; Laursen KB; Orfali N; Cahill MR; Mongan NP; Gudas LJ; McKenna SL
Front Oncol; 2022; 12():848517. PubMed ID: 35280824
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
Orfali N; O'Donovan TR; Cahill MR; Benjamin D; Nanus DM; McKenna SL; Gudas LJ; Mongan NP
Eur J Haematol; 2020 Mar; 104(3):236-250. PubMed ID: 31811682
[TBL] [Abstract][Full Text] [Related]
3. The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.
de Almeida LY; Pereira-Martins DA; Weinhäuser I; Ortiz C; Cândido LA; Lange AP; De Abreu NF; Mendonza SES; de Deus Wagatsuma VM; Do Nascimento MC; Paiva HH; Alves-Paiva RM; Bonaldo CCOM; Nascimento DC; Alves-Filho JC; Scheucher PS; Lima ASG; Schuringa JJ; Ammantuna E; Ottone T; Noguera NI; Araujo CL; Rego EM
Front Oncol; 2021; 11():686445. PubMed ID: 34650910
[TBL] [Abstract][Full Text] [Related]
4. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
5. HSPA8 Chaperone Complex Drives Chaperone-Mediated Autophagy Regulation in Acute Promyelocytic Leukemia Cell Differentiation.
Rafiq S; Mungure I; Banz Y; Niklaus NJ; Kaufmann T; Müller S; Jacquel A; Robert G; Auberger P; Torbett BE; Muller S; Tschan MP; Humbert M
Pharmacology; 2024 Apr; ():1-15. PubMed ID: 38569476
[TBL] [Abstract][Full Text] [Related]
6. Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line.
Yoon SG; Cheong HJ; Kim SJ; Kim KH; Lee SC; Lee N; Park HS; Won JH
Cancer Res Treat; 2013 Jun; 45(2):126-33. PubMed ID: 23864846
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells.
Orfali N; Shan-Krauer D; O'Donovan TR; Mongan NP; Gudas LJ; Cahill MR; Tschan MP; McKenna SL
Mol Oncol; 2020 Jun; 14(6):1297-1309. PubMed ID: 31820845
[TBL] [Abstract][Full Text] [Related]
8. Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation.
Orfali N; O'Donovan TR; Nyhan MJ; Britschgi A; Tschan MP; Cahill MR; Mongan NP; Gudas LJ; McKenna SL
Exp Hematol; 2015 Sep; 43(9):781-93.e2. PubMed ID: 25986473
[TBL] [Abstract][Full Text] [Related]
9. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
[TBL] [Abstract][Full Text] [Related]
10. The autophagy scaffold protein ALFY is critical for the granulocytic differentiation of AML cells.
Schläfli AM; Isakson P; Garattini E; Simonsen A; Tschan MP
Sci Rep; 2017 Oct; 7(1):12980. PubMed ID: 29021535
[TBL] [Abstract][Full Text] [Related]
11. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
[TBL] [Abstract][Full Text] [Related]
12. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells.
Valenzuela M; Glorieux C; Stockis J; Sid B; Sandoval JM; Felipe KB; Kviecinski MR; Verrax J; Buc Calderon P
Br J Cancer; 2014 Aug; 111(5):874-82. PubMed ID: 25003661
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
15. Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL.
Humbert M; Federzoni EA; Tschan MP
J Leukoc Biol; 2017 Dec; 102(6):1357-1370. PubMed ID: 28978663
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
[TBL] [Abstract][Full Text] [Related]
17. Autophagy is Required to Regulate Mitochondria Renewal, Cell Attachment, and All-trans-Retinoic Acid-Induced Differentiation in NB4 Acute Promyelocytic Leukemia Cells.
Tekedereli I; Akar U; Alpay SN; Lopez-Berestein G; Ozpolat B
J Environ Pathol Toxicol Oncol; 2019; 38(1):13-20. PubMed ID: 30806286
[TBL] [Abstract][Full Text] [Related]
18. Retinoid receptor signaling and autophagy in acute promyelocytic leukemia.
Orfali N; McKenna SL; Cahill MR; Gudas LJ; Mongan NP
Exp Cell Res; 2014 May; 324(1):1-12. PubMed ID: 24694321
[TBL] [Abstract][Full Text] [Related]
19. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
